ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
2,2,Otitis externa,Ear infections,Infections - pathogen unspecified,Infec,N
3,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
4,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
4,2,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
5,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
5,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
6,1,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
7,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
8,1,Respiratory distress,Breathing abnormalities,Respiratory disorders NEC,Resp,N
9,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
10,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
11,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
12,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
13,1,Otitis externa,Ear infections,Infections - pathogen unspecified,Infec,N
14,1,Thermal burns of eye,Thermal burns,Injuries by physical agents,Inj&P,N
15,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
16,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
17,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
18,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
19,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
20,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
21,1,Otitis externa,Ear infections,Infections - pathogen unspecified,Infec,N
22,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
23,1,Otitis externa,Ear infections,Infections - pathogen unspecified,Infec,N
24,1,Sudden infant death syndrome,Death and sudden death,Fatal outcomes,Genrl,Y
25,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
26,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
27,1,Cheilitis,Oral soft tissue disorders NEC,Oral soft tissue conditions,Gastr,N
28,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
28,2,Gastric dilatation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
29,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
30,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
31,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
32,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
33,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
34,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
35,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
36,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
37,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
38,1,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
39,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
39,2,Thermal burn,Thermal burns,Injuries by physical agents,Inj&P,N
40,1,Apnoeic attack,Breathing abnormalities,Respiratory disorders NEC,Resp,N
40,2,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
40,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
40,4,Periorbital oedema,Ocular disorders NEC,Eye disorders NEC,Eye,N
40,5,Salivary hypersecretion,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
41,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
41,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
42,1,Chemical burn of skin,Chemical injuries,"Exposures, chemical injuries and poisoning",Inj&P,N
42,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
43,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
43,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
43,3,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
44,1,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
44,2,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
45,1,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
45,2,Dry throat,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
45,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
46,1,Chapped lips,Oral soft tissue disorders NEC,Oral soft tissue conditions,Gastr,N
46,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
47,1,Inflammation,Inflammations,General system disorders NEC,Genrl,N
48,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
48,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
49,1,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
50,1,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
51,1,Middle ear disorder,Middle ear disorders NEC,Middle ear disorders (excl congenital),Ear,N
51,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
52,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
52,2,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
52,3,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
53,1,Accidental exposure to product,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
53,2,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
54,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
54,2,Duodenitis,Gastrointestinal inflammatory disorders NEC,Gastrointestinal inflammatory conditions,Gastr,N
54,3,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
54,4,Gastric ulcer,Gastric ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
54,5,Helicobacter infection,Helicobacter infections,Bacterial infectious disorders,Infec,N
54,6,Hiatus hernia,Diaphragmatic hernias,Abdominal hernias and other abdominal wall conditions,Gastr,N
54,7,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
54,8,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
55,1,Application site burn,Application site reactions,Administration site reactions,Genrl,N
55,2,Application site pain,Application site reactions,Administration site reactions,Genrl,N
55,3,Deafness,Hearing losses,Hearing disorders,Ear,N
55,4,Otitis externa,Ear infections,Infections - pathogen unspecified,Infec,N
55,5,Otorrhoea,Ear disorders NEC,Aural disorders NEC,Ear,N
55,6,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
56,1,Deafness,Hearing losses,Hearing disorders,Ear,N
56,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
57,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
57,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
58,1,Deafness,Hearing losses,Hearing disorders,Ear,N
59,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
59,2,Scab,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
59,3,Skin haemorrhage,Skin haemorrhages,Skin vascular abnormalities,Skin,N
59,4,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
60,1,Deafness,Hearing losses,Hearing disorders,Ear,N
60,2,Ear pain,Ear disorders NEC,Aural disorders NEC,Ear,N
61,1,Deafness,Hearing losses,Hearing disorders,Ear,N
61,2,Ear pain,Ear disorders NEC,Aural disorders NEC,Ear,N
